Effector lymphocytes in autoimmunity

被引:65
作者
Santamaria, P [1 ]
机构
[1] Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/S0952-7915(01)00276-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune diseases result from complex interactions among different T- and B-lymphocyte subpopulations that target a rapidly growing number of autoantigens on different cell types. The etiology of most spontaneous autoimmune disorders, and both the kinetics and hierarchy of the underlying autoimmune responses are poorly understood. However, important advances have been made in recent years in our understanding of how autoreactive lymphocytes cause tissue damage, including the discovery that granzyme B binds to a cell surface receptor on target cells. This review is an attempt to summarize recent developments in this area.
引用
收藏
页码:663 / 669
页数:7
相关论文
共 76 条
[31]   Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor α chain-deficient mice [J].
Iijima, H ;
Takahashi, I ;
Kishi, D ;
Kim, JK ;
Kawano, S ;
Hori, M ;
Kiyono, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :607-615
[32]   Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice [J].
Itoh, N ;
Imagawa, A ;
Hanafusa, T ;
Waguri, M ;
Yamamoto, K ;
Iwahashi, H ;
Moriwaki, M ;
Nakajima, H ;
Miyagawa, J ;
Namba, M ;
Makino, S ;
Nagata, S ;
Kono, N ;
Matsuzawa, Y .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) :613-618
[33]   Different modes of pathogenesis in T-cell-dependent autoimmunity:: clues from two TCR transgenic systems [J].
Ji, H ;
Korganow, AS ;
Mangialaio, S ;
Höglund, P ;
André, I ;
Lühder, F ;
Gonzalez, A ;
Poirot, L ;
Benoist, C ;
Mathis, D .
IMMUNOLOGICAL REVIEWS, 1999, 169 :139-146
[34]   Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice [J].
Kagi, D ;
Odermatt, B ;
Seiler, P ;
Zinkernagel, RM ;
Mak, TW ;
Hengartner, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :989-997
[35]   Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity [J].
Kagi, D ;
Odermatt, B ;
Ohashi, PS ;
Zinkernagel, RM ;
Hengartner, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2143-2152
[36]   TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages [J].
Kaplan, MJ ;
Ray, D ;
Mo, RR ;
Yung, RL ;
Richardson, BC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :2897-2904
[37]   Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination [J].
Kassiotis, G ;
Kollias, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (04) :427-434
[38]   Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand [J].
Kong, YY ;
Feïge, U ;
Sarosi, I ;
Bolon, B ;
Tafuri, A ;
Morony, S ;
Capparelli, C ;
Li, J ;
Elliott, R ;
McCabe, S ;
Wong, T ;
Campagnuolo, G ;
Moran, E ;
Bogoch, ER ;
Van, G ;
Nguyen, LT ;
Ohashi, PS ;
Lacey, DL ;
Fish, E ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 402 (6759) :304-309
[39]  
Kreuwel HTC, 1999, J IMMUNOL, V163, P4335
[40]  
Lehmann C, 2000, BLOOD, V96, P594